Adjusted annual decline in eGFR in patients with HCV and CKD and those with CKD alone. Adjusted for age, sex, race/ethnicity, CKD stage, diabetes, hypertension, HIV, hepatitis B infection, myocardial infarction, end-stage liver disease; and interactions between time and HCV and CKD status, diabetes, hepatitis B virus, and race.